PART I . Forward-Looking Statements This Annual Report contains forward-looking statements within the meaning of Section27A of the Securities Act and Section21E of the Exchange Act that are based on our managements beliefs and assumptions and on information currently available to our management. Forward-looking statements include, but are not limited to: our ability to successfully commercialize ANKTIVA globally in NMIBC, NSCLC or other indications or any future approved products in the U.S. or ...
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-23 | 2025-12-31 | 0001326110-26-000030 | EDGAR | 153K words |
| 2025-03-03 | 2024-12-31 | 0001326110-25-000033 | EDGAR | — |
| 2024-03-19 | 2023-12-31 | 0001326110-24-000037 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0001326110-23-000018 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001326110-22-000011 | EDGAR | — |
| 2021-03-04 | 2020-12-31 | 0001564590-21-010945 | EDGAR | — |
| 2020-03-25 | 2019-12-31 | 0001564590-20-012816 | EDGAR | — |
| 2019-03-13 | 2018-12-31 | 0001564590-19-007562 | EDGAR | — |
| 2018-03-12 | 2017-12-31 | 0001564590-18-005290 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001564590-17-004430 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-04 | 2026-06-30 | 0001326110-26-000079 | EDGAR | — |
| 2025-11-05 | 2025-09-30 | 0001326110-25-000139 | EDGAR | 110K words |
| 2025-08-05 | 2025-06-30 | 0001326110-25-000114 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001326110-25-000071 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001326110-24-000111 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0001326110-24-000103 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001326110-24-000064 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001326110-23-000147 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001326110-23-000098 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001326110-23-000064 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001326110-22-000074 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001326110-22-000058 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0001326110-26-000077 | EDGAR | — |
| 2026-07-30 | 0001326110-26-000071 | EDGAR | — |
| 2026-04-06 | 0001193125-26-142932 | EDGAR | 1K words |
| 2026-03-31 | 0001193125-26-133363 | EDGAR | — |
| 2026-02-23 | 0001326110-26-000025 | EDGAR | — |
| 2026-02-18 | 0001326110-26-000018 | EDGAR | — |
| 2026-01-26 | 0001326110-26-000014 | EDGAR | — |
| 2026-01-15 | 0001326110-26-000008 | EDGAR | — |
| 2026-01-14 | 0001326110-26-000004 | EDGAR | — |
| 2025-12-29 | 0001193125-25-331244 | EDGAR | — |
175 total filings indexed. 143 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001326110 |
| Ticker | IBRX |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.immunitybio.com |
| Listed | 2021-03-10 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IBRX (~200 tokens, structured JSON with cryptographic provenance)